Artificial life and therapeutic vaccines against cancers that originate in viruses

Abstract

The construction of artificial life processes that seek to contribute to the development of therapeutic vaccines to treat human cancers, which have their origin in infectious processes caused by viruses, requires research on three fronts. On the one hand, to know the life cycle of the virus under study, as well as to recognize the mechanisms and strategies that it can implement to attack its host and proceed to infect it. On the other hand, to acknowledge the components, mechanisms and strategies that the immune system develops to identify the presence of a stranger and prepare to repel it, in response to the kind of attack that poses. And finally, to design the strategies, that exogenously, allow activating the host’s immune system so that it prepares answers with objectives aimed at counteracting the injuries caused by the virus that attacks it. This chapter describes in general, the methods that through a process of artificial life, allow to simulate the interactions that arise between human immune system, pathogen (viruses as etiological agents of cancer), and therapeutic vaccines to treat lesions that originates in the activity of this type of pathogen.